Vivek Jain - Mar 7, 2024 Form 4 Insider Report for ICU MEDICAL INC/DE (ICUI)

Role: Chairman and CEO, Director
Signature: By: Paula Darbyshire, Attorney-in-fact For: Vivek Jain
Stock symbol: ICUI
Transactions as of: Mar 7, 2024
Transactions value $: -$1,923,985
Form type: 4
Date filed: 3/11/2024, 04:26 PM
Previous filing: Feb 14, 2024
Next filing: Mar 18, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ICUI	Common Stock	Options Exercise	$0	+3.22K	+3.69%	$0.00	90.5K	Mar 7, 2024	Direct	F1
transaction	ICUI	Common Stock	Tax liability	-$186K	-1.76K	-1.95%	$105.39	88.8K	Mar 7, 2024	Direct
transaction	ICUI	Common Stock	Options Exercise	$0	+19.3K	+21.75%	$0.00	108K	Mar 7, 2024	Direct	F2
transaction	ICUI	Common Stock	Tax liability	-$1.12M	-10.6K	-9.8%	$105.39	97.5K	Mar 7, 2024	Direct
transaction	ICUI	Common Stock	Options Exercise	$0	+2.53K	+2.59%	$0.00	100K	Mar 8, 2024	Direct	F1
transaction	ICUI	Common Stock	Tax liability	-$145K	-1.38K	-1.38%	$104.52	98.6K	Mar 8, 2024	Direct
transaction	ICUI	Common Stock	Options Exercise	$0	+8.33K	+8.45%	$0.00	107K	Mar 8, 2024	Direct	F2
transaction	ICUI	Common Stock	Tax liability	-$478K	-4.57K	-4.27%	$104.52	102K	Mar 8, 2024	Direct
holding	ICUI	Common Stock						88.7K	Mar 7, 2024	by Trust

Showing 1 to 9 of 9 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ICUI	Common Stock	Options Exercise	$0	-2.53K	-100%	$0.00^*	0	Mar 8, 2024	Common Stock	2.53K	$0.00	Direct	F1, F3, F4, F5
transaction	ICUI	Common Stock	Options Exercise	$0	-3.22K	-50%	$0.00	3.22K	Mar 7, 2024	Common Stock	3.22K	$0.00	Direct	F1, F3, F4, F5
transaction	ICUI	Performance Shares	Options Exercise	$0	-19.3K	-100%	$0.00^*	0	Mar 7, 2024	Common Stock	19.3K	$0.00	Direct	F2, F6, F7
transaction	ICUI	Performance Shares	Options Exercise	$0	-8.33K	-100%	$0.00^*	0	Mar 8, 2024	Common Stock	8.33K	$0.00	Direct	F2, F6, F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These securities are Restricted Stock Units.
F2	These Securities are Performance-based Restricted Stock Units (PRSU).
F3	There is neither a purchase price nor an exercise price for the Restricted Stock Units.
F4	One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.
F5	These are restricted stock units that fully vest 3 years from the grant date.
F6	There is neither a purchase price nor an exercise price for the PRSUs.
F7	These PRSUs were granted on March 7, 2022 and had a 2-year cliff-vest performance period subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 200% of the original grant.
F8	These PRSUs were granted on March 8, 2021 and had a 3-Year cliff-vest subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 110% of the original grant.